Advertisement
No access
Research Articles

Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level

Science
24 May 2002
Vol 296, Issue 5572
pp. 1439-1443

Abstract

Antigen-specific T cell immunity is HLA-restricted. Human immunodeficiency virus–type 1 (HIV-1) mutations that allow escape from host immune responses may therefore be HLA allele–specific. We analyzed HIV-1 reverse transcriptase sequences from a large HLA-diverse population of HIV-1–infected individuals. Polymorphisms in HIV-1 were most evident at sites of least functional or structural constraint and frequently were associated with particular host HLA class I alleles. Absence of polymorphism was also HLA allele–specific. At a population level, the degree of HLA-associated selection in viral sequence was predictive of viral load. These results support a fundamental role for HLA-restricted immune responses in driving and shaping HIV-1 evolution in vivo.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (1069660s1_large.jpeg)
File (1069660s1_med.gif)
File (1069660s1_thumb.gif)
File (moorefigs2.pdf)

REFERENCES AND NOTES

1
McMichael A. J., Rowland-Jones S. L., Nature 410, 980 (2001).
2
Evans D. T., et al., Nature Med. 5, 1270 (1999).
3
Allen T. M., et al., Nature 407, 386 (2000).
4
Barouch D. H., et al., Nature 415, 335 (2002).
5
Del Val M., Schlicht H. J., Ruppert T., Reddehase M. J., Koszinowski U. H., Cell 66, 1145 (1991).
6
Wrobel J. A., et al., Proc. Natl. Acad. Sci. U.S.A. 95, 638 (1998).
7
Layne S. P., et al., Virology 189, 695 (1992).
8
Walker B. D., et al., Science 240, 64 (1988).
9
Hosmalin A., et al., Proc. Natl. Acad. Sci U.S.A. 87, 2344 (1990).
10
Mallal S. A., J. AIDS Hum. Retrovirol. 17, S23 (1998).
11
The Western Australian HIV Cohort Study is a prospective observational cohort study of HIV-infected patients that was established in 1983. Comprehensive demographic, clinical, and laboratory data are collected on all individuals and maintained in an electronic database. Participants in the cohort typically have had HIV-1 RT proviral DNA sequencing performed at first presentation and before antiretroviral therapy and serially posttreatment as required for clinical care since 1995.
12
HIV-1 DNA was extracted from buffy coats (QIAMP DNA blood mini kit; Qiagen, Hilden, Germany) and codons 20 to 227 of RT were amplified by polymerase chain reaction (PCR). A nested second round PCR was done, and the PCR product was purified with Bresatec purification columns and sequenced in forward and reverse directions with a model 373 ABI DNA sequencer. Raw sequence was manually edited with software packages Factura and MT Navigator (PE Biosystems).
13
All HLA-A and -B broad alleles were typed by the standard National Institutes of Health complement-dependent microtoxicity technique. Fifty-one HLA-B5 individuals and 57 HLA-B35 individuals had HLA-B sequence amplified with primers to the first intronic dimorphism, and products were sequenced by automated sequencing.
14
Ratner L., et al., Nature 313, 277 (1985).
15
For supplementary analyses, detailed description of all statistical methods, and a full version of Fig. 1, see ScienceOnline at www.sciencemag.org/cgi/content/full/296/5572/1439/DC1.
16
F. L. Ramsey, D. W. Schafer, in The Statistical Sleuth. A Course in Methods of Data Analysis (Duxbury Press, Belmont, CA 1997), pp. 10–13, chap. 1.3.
17
B. T. M. Korber et al., HIV Molecular Immunology Database 1999 (Theoretical Biology and Biophysics, Los Alamos, New Mexico, 1999).
18
Kuttler C., et al., J. Mol. Biol. 298, 417 (2000).
19
de Groot A. S., et al., AIDS Res. Hum. Retroviruses 13, 529 (1997).
20
Sipsas N. V., et al., J. Clin. Invest. 99, 752 (1997).
21
Wagner L., et al., Nature 391, 908 (1998).
22
Campos-Lima P. O., et al., Science 260, 98 (1993).
23
Campos-Lima P. O., Levitsky V., Imreh M. P., Gavioli R., Masucci M. G., J. Exp. Med. 186, 83 (1997).
24
Hay C. M., et al., J. Virol. 73, 5509 (1999).
25
Brander C., et al., J. Clin. Invest. 101, 2559 (1998).
26
Shankar P., Sprang H., Lieberman J., J. AIDS Hum. Retrovirol. 19, 111 (1998).
27
Rowland-Jones S., et al., Nature Med. 1, 59 (1995).
28
Fowke K. R., et al., Lancet 348, 1347 (1996).
29
Rowland-Jones S. L., et al., J. Clin. Invest. 102, 1758 (1998).
30
Rowland-Jones S. L., et al., Immunol. Lett. 66, 9 (1999).
31
Mazzoli S., et al., Nature Med. 3, 1250 (1997).
32
Fabio G., et al., Clin. Exp. Immunol. 87, 20 (1992).
33
The viral load assay used until November 1999 was the HIV Amplicor (Roche Diagnostics, Branchburg, NJ) (lower limit of detection, 400 copies per ml). The Roche Amplicor HIV monitor version 1.5, Ultrasensitive (lower limit of detection, 50 copies per ml) was used thereafter.
34
Goulder P. J. R., et al., Immunol. Rev. 159, 17 (1997).
35
Schmitt M., et al., AIDS 14, 653 (2000).
36
We are indebted to participants in the WA HIV Cohort Study as well as past and present clinical and laboratory staff of the Department of Clinical Immunology and Biochemical Genetics, Royal Perth Hospital, Western Australia. We thank S. Rowland-Jones for helpful comments on the manuscript. C.B.M. was recipient of an Australian Postgraduate Award, and M.J. is recipient of a National Health and Medical Research Council of Australia Postgraduate Scholarship.

(0)eLetters

eLetters is a forum for ongoing peer review. eLetters are not edited, proofread, or indexed, but they are screened. eLetters should provide substantive and scholarly commentary on the article. Embedded figures cannot be submitted, and we discourage the use of figures within eLetters in general. If a figure is essential, please include a link to the figure within the text of the eLetter. Please read our Terms of Service before submitting an eLetter.

Log In to Submit a Response

No eLetters have been published for this article yet.

Information & Authors

Information

Published In

Science
Volume 296 | Issue 5572
24 May 2002

Submission history

Received: 9 January 2002
Accepted: 27 March 2002
Published in print: 24 May 2002

Permissions

Request permissions for this article.

Authors

Affiliations

Corey B. Moore
Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Level 2 North Block, Royal Perth Hospital, Wellington Street, WA 6000, Australia.
Mina John
Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Level 2 North Block, Royal Perth Hospital, Wellington Street, WA 6000, Australia.
Department of Clinical Immunology and Biochemical Genetics, Royal Perth Hospital.
Ian R. James
Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Level 2 North Block, Royal Perth Hospital, Wellington Street, WA 6000, Australia.
Frank T. Christiansen
Department of Clinical Immunology and Biochemical Genetics, Royal Perth Hospital.
Department of Pathology, University of Western Australia, WA 6009, Australia.
Campbell S. Witt
Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Level 2 North Block, Royal Perth Hospital, Wellington Street, WA 6000, Australia.
Department of Clinical Immunology and Biochemical Genetics, Royal Perth Hospital.
Simon A. Mallal*
Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Level 2 North Block, Royal Perth Hospital, Wellington Street, WA 6000, Australia.
Department of Clinical Immunology and Biochemical Genetics, Royal Perth Hospital.

Notes

*
To whom correspondence should be addressed. E-mail: [email protected]

Metrics & Citations

Metrics

Article Usage

Altmetrics

Citations

Cite as

Export citation

Select the format you want to export the citation of this publication.

Cited by

  1. Sequence diversity of hepatitis D virus in Mongolia, Frontiers in Medicine, 10, (2023).https://doi.org/10.3389/fmed.2023.1108543
    Crossref
  2. Single-cycle influenza virus vaccine generates lung CD8+ Trm that cross-react against viral variants and subvert virus escape mutants, Science Advances, 9, 36, (2023)./doi/10.1126/sciadv.adg3469
    Abstract
  3. Nano-vaccines for gene delivery against HIV-1 infection, Expert Review of Vaccines, 22, 1, (315-326), (2023).https://doi.org/10.1080/14760584.2023.2193266
    Crossref
  4. Baseline QOL, QOL-relevant HLA-restricted HERV gene-derived peptides, and survival outcomes in gastric cancer, Annals of Cancer Research and Therapy, 30, 2, (55-66), (2022).https://doi.org/10.4993/acrt.30.55
    Crossref
  5. On the Evolutionary Trajectory of SARS-CoV-2: Host Immunity as a Driver of Adaptation in RNA Viruses, Viruses, 15, 1, (70), (2022).https://doi.org/10.3390/v15010070
    Crossref
  6. High Level of Pre-Treatment HIV-1 Drug Resistance and Its Association with HLA Class I-Mediated Restriction in the Pumwani Sex Worker Cohort, Viruses, 14, 2, (273), (2022).https://doi.org/10.3390/v14020273
    Crossref
  7. Adaptation to HLA-associated immune pressure over the course of HIV infection and in circulating HIV-1 strains, PLOS Pathogens, 18, 12, (e1010965), (2022).https://doi.org/10.1371/journal.ppat.1010965
    Crossref
  8. HLA-II-Associated HIV-1 Adaptation Decreases CD4 + T-Cell Responses in HIV-1 Vaccine Recipients , Journal of Virology, 96, 17, (2022).https://doi.org/10.1128/jvi.01191-22
    Crossref
  9. Next-generation T cell–activating vaccination increases influenza virus mutation prevalence, Science Advances, 8, 14, (2022)./doi/10.1126/sciadv.abl5209
    Abstract
  10. SARS-CoV-2 intra-host single-nucleotide variants associated with disease severity, Virus Evolution, 8, 2, (2022).https://doi.org/10.1093/ve/veac106
    Crossref
  11. See more
Loading...

View Options

Check Access

Log in to view the full text

AAAS ID LOGIN

AAAS login provides access to Science for AAAS Members, and access to other journals in the Science family to users who have purchased individual subscriptions.

Log in via OpenAthens.
Log in via Shibboleth.

More options

Purchase digital access to this article

Download and print this article for your personal scholarly, research, and educational use.

Purchase this issue in print

Buy a single issue of Science for just $15 USD.

View options

PDF format

Download this article as a PDF file

Download PDF

Full Text

FULL TEXT

Media

Figures

Multimedia

Tables

Share

Share

Share article link

Share on social media